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Abstract
We describe the sudden death of a middle-aged man while having a sauna under the influence ofα-pyrrolidinovalerophenone (α-
PVP) (PM blood concentration: 0.8 mg/L), amphetamine (0.34 mg/L), and other drugs (buprenorphine, benzodiazepines), and
engaging in solitary sexual activities. The drugs’ effects on the cardio-circulatory system and on body thermoregulation com-
bined with the high temperatures are likely to have been central mechanisms leading to death. The high levels of adrenaline
triggered by sexual arousal and the respiratory depression caused by buprenorphine, in association with benzodiazepines, may
have also contributed to his death. This previously unreported type of accidental autoerotic death illustrates the risk of using
amphetamine-like sympathomimetic drugs (e.g. cathinone derivates) in hot environments such as a sauna, and during sexual
activities therein.
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Introduction
Deaths associated with autoerotic activities have been de-
scribed in the medical literature for over a century [1].
Although several definitions and criteria for classification ex-
ist [1–4], autoerotic fatalities can merely be seen as “deaths
that occur as the result of or in association with masturbation
or other autoerotic activity” [1]. Byard and Bramwell [2] have
recommended that the use of this term is restricted to acciden-
tal deaths that occur “during individual, usually solitary, sex-
ual activity in which a device, apparatus, or prop that was
employed to enhance the sexual stimulation of the deceased
in some way caused unintended death”. The most frequent
autoerotic accidental death (AAD) occurs by asphyxia, usual-
ly by hanging, and is the one frequently defined as typical [1,
5], but descriptions cover a wide range of atypical AAD [1, 3,
6–9].
We describe an atypical AAD of a middle-aged man during
a s a u n a w h i l e u n d e r t h e i n f l u e n c e o f α -
pyrrolidinovalerophenone (α-PVP), amphetamine, and other
drugs.
Case report
Case history
A Caucasian male in his mid-40s was found dead, in late
spring, in the sauna area of an apartment building, where he
lived with his mother. The man had a history of multidrug
abuse and was participating in a buprenorphine replacement
therapy program (Suboxone®). He had been diagnosed also
* Philippe Lunetta
philippe.lunetta@utu.fi
Pirkko Kriikku
pirkko.kriikku@thl.fi
Julius Tikka
julius.tikka@thl.fi
Ilkka Ojanperä
ilkka.ojanpera@helsinki.fi
1 Department of Biomedicine, Forensic Medicine, University of
Turku, Turku, Finland
2 Department of Forensic Medicine, University of Oulu, Oulu, Finland
3 Finnish Institute for Health and Welfare, Forensic Toxicology Unit,
Helsinki, Finland
4 Department of Forensic Medicine, University of Helsinki,
Helsinki, Finland
5 Finnish Institute for Health and Welfare, Forensic Medicine Unit,
Helsinki, Finland
https://doi.org/10.1007/s12024-020-00236-1
/ Published online: 26 March 2020
Forensic Science, Medicine and Pathology (2020) 16:493–497
with attention deficit hyperactivity disorder (ADHD), for
which his treatment was methylphenidate and diazepam.
The victim’s mother had started an hour-long sauna-shift at
9:00 pm but returned to her apartment at 9:30 pm, at which
time the victim began his sauna. After approximately mid-
night, the mother noticed that her son had not returned from
the sauna. The sauna electrical heating system had shut off
automatically at 10:00 pm and, simultaneously, the door to
the sauna department was automatically closed by an electri-
cal lock. At 1:48 am, the mother alerted the residence caretak-
er, who opened the sauna door at 2:30 am. The victim was
found dead on the second highest bench of the sauna, in a
supine position partially on his right side. He was unclothed
except for a woman’s bra, which was placed around his hips.
On the upper bench were a pornographic magazine and a wig.
Beneath the benches were an anal dildo and two balloons that
likely had been positioned under the victims’ bra.
No resuscitation attempts took place, as secondary signs of
death were evident. At the time of police-scene investigation,
around 3:00 am, the temperature in the sauna roomwas 43 °C.
Police investigation revealed no suicide note nor any findings
suggesting foul play.
Autopsy findings
A medico-legal autopsy was performed 11 days later. At ex-
ternal examination, the victim’s body showed mild to moder-
ate burn-like lesions caused by exposure to heat in the sauna.
In addition to a few scattered bruises and abrasions, no other
external signs of mechanical trauma were detectable. At inter-
nal examination, the brain and lungs showed congestion and
moderate edema. Microscopic examination of sections of the
left ventricular wall and ventricular septum showed myocar-
dial contraction band necrosis and fragmentation of myocar-
dial cells and dissection at the intercalated disks, chronic hep-
atitis and moderate hepatic fibrosis as well as, in the lungs,
some foreign body granulomas consistent with intravenous
drug abuse.
Toxicological analysis
Post-mortem (PM) blood samples from femoral veins were
positive for α-PVP (0.81 mg/L), amphetamine (0.34 mg/L),
alprazolam (<0.005 mg/L; therapeutic range 0.01–0.02 mg/
L), and oxazepam (0.18 mg/L; therapeutic range 0.1–
1.4 mg/L) (GC-MS), as well as buprenorphine (8.7μg/L; ther-
apeutic range 0.5-10 μg/L), and norbuprenorphine (57 μg/L).
In addition, traces of naloxone were detectable in PM blood,
which is in accordance with the victim having been in
buprenorphine replacement therapy. Amphetamine, α-PVP,
and oxazepam were also detectable in the vitreous humor.
No alcohols or other positive findings were detected either
in blood, urine, or vitreous humor.
Based on circumstantial data, medical history, and autopsy
findings, the cause of death was certified as “fatal poisoning
by α-PVP and amphetamine” and the manner of death “unin-
tentional”. “Effect of high temperature (hot air, sauna)” was
deemed a contributing cause of death.
Discussion
Cases of AAD are often classified as either typical (resulting
from different types of mechanical asphyxia), or atypical (in-
volving sexual self-stimulation by other means) [1]. The latter
include electrocution, foreign-body insertion, intoxication,
and even drowning [6, 7, 9–14]. A few cases of AAD related
to or associated with cold exposure have been reported [1, 14].
Conversely, we are aware of only one AAD directly linked to
environmental hyperthermia. That male victim was found
dead outdoors (39 °C) wearing female clothes, including sev-
en layered pairs of pantyhose, and had used a prescription
medication (benztropine) causing, as a side-effect, hyperther-
mia [11]. Moreover, in some AAD cases, ones characterized
by body-wrapping causing asphyxia, hyperthermia may have
been a contributing factor [15]. Most often, PM toxicology in
AAD is negative [8]. However, in addition to alcohol-positive
cases and fatalities involving gas mixtures, some medicinal
and illicit drugs have sporadically been detectable [5–9, 14].
In the present case, PM toxicology revealed α-
p y r r o l i d i n o v a l e r o p h e n o n e ( α - P V P , α -
pyrrolidinopentiophenone) in the blood in addition to amphet-
amine, buprenorphine, and benzodiazepines. The synthetic
cathinone-derivate α-PVP, which is structurally related to
pyrovalerone, acts as a central nervous system stimulant with
effects similar to those of amphetamines and cocaine.
Cathinone occurs naturally in a plant known as “khat”
(Catha edulis), which has traditionally been chewed in
Eastern Africa and in some Arab countries for its stimulant
effects [16–18]. During recent decades, synthetic cathinones
have been meant to replace more strictly regulated stimulants
(e.g. cocaine, MDMA, other amphetamines) and to provide
legal chemicals with equal or greater effects and abuse poten-
tial [19, 20]. Synthetic cathinones are commonly self-
administered by tablet ingestion or powder insufflation, more
rarely by intravenous or -muscular injection [19, 21].
Synthetic α-PVP has its peak effect within 10 to 40 min after
intake, and its effects last for up to 1–3 h [18]. Users of syn-
thetic cathinones report enhanced energy, euphoria, and em-
pathy in social interactions, as well as increased libido
[21–23]. Although perceived as relatively safe, these drugs
have adverse sympathomimetic effects including arrhythmias,
hypertension, hyperthermia, and seizures, as well as psychotic
symptoms such as agitation and hallucinations [17, 19, 21, 22,
24].
494 Forensic Sci Med Pathol (2020) 16:493–497
Thus far, no data exist that can substantiate the toxic and
lethal concentrations of α-PVP in humans [18, 19]. In the
current case, the α-PVP PM blood concentration (0.81 mg/
L) was fairly high compared to those concentrations detected
in 47 individuals who underwent a medico-legal autopsy in
Finland from January 2010 to September 2019 (unpublished
data) and who tested positive for α-PVP in their blood (age
range: 19–62, mean: 26.6 years, male-to-female ratio: 8.4). In
this Finnish series (28 accidents, 9 suicides, 7 natural deaths, 1
homicide, and 2 undetermined deaths), the α-PVP PM blood
concentration ranged from <0.02 mg/L to 2 mg/L, but only
three cases showed blood concentrations higher than the con-
centration detectable in our case (0.91 mg/L, 1.3 mg/L,
2.0 mg/L). Only two cases were classified as accidental poi-
soning due to α-PVP alone (2.0 mg/L; 0.04 mg/L). In the
latter case, intravenous use of α-PVP led to multiple organ
damage and eventually death at hospital. At the time of sam-
pling, some time had elapsed from the administration of α-
PVP to death, which explains the low concentration of the
drug. In addition to the cases in which α-PVP was the primary
intoxicant, 14 cases, excluding the present one, involved α-
PVP at a fatal multi-drug intoxication level (blood concentra-
tions up to 0.64 mg/L).
The medical literature reports relatively few data on fatalα-
PVP poisonings. A European Union survey involving eight
state members reported 115 deaths between 2012 and 2015 in
which α-PVP was analytically confirmed in one or more bio-
logical samples [25]. In 23 of these cases, α-PVP was the
cause or a contributing cause of death, and in 5 of these cases,
it was the only drug detected. In a sudden death during re-
straint of an individual with symptoms of excited delirium
after self-administration of α-PVP, the PM blood concentra-
tion was 0.41 mg/L [26], whereas in two other fatal α-PVP
poisonings, the concentrations were 0.17 mg/L and 0.85 mg/L
[27, 28]. A US study has reported three fatal α-PVP poison-
ings with a PM blood concentration of 0.033, 0.054, and >
20 mg/L, the last one occurring in custody after the victim
swallowed the drug [29]. As for non-fatal concentrations, in
a series of 18 subjects suspected of driving under the influence
of drugs, the blood concentration of α-PVP ranged from 0.03
to >0.09 mg/L, but only 4 drivers reported side-effects consis-
tent with those of synthetic cathinones [29].
To the best of our knowledge, although amphetamine and
other illicit drugs have been sporadically detected in victims of
sauna death [30], neither AADs in a sauna nor deaths in a
sauna associated with use of α-PVP have been reported thus
far.
In the present case, the sauna was electrical (as is generally
the case in saunas located in residence buildings in Finland),
and its heating was interrupted by a timer at the end of the final
shift. As Finnish saunas are heated to 60–80 °C or more [31,
32], and the victim’s mother was sauna-bathing until 9:30 p.m.
when the victim arrived at the sauna, the victim was likely
exposed to significant heat prior his death, although the sauna
had significantly cooled by the time the police arrived at the
scene.
During a Finnish sauna (temperature 80–100 °C, humidity
10–20%) the skin temperature rises within a few minutes to
40 °C, and the core temperature rises approximately 1 °C in
30 min, while the heart rate increases; heat is lost by increased
cutaneous blood flow, vasodilatation, and sweating [32]. In
most sauna deaths, a pre-existing cardiac disease or acute al-
cohol consumption, or both, represent the underlying or con-
tributing cause of death [30, 31]. Exposure to sauna heat may
also alter drug pharmacokinetics, especially for trans-dermally
administered drugs such as nitroglycerine [32] and fentanyl
(unpublished case). Medications and illicit drugs having a
thermogenic effect (e.g. amphetamine-like drugs including
synthetic cathinones), when associated with exposure to over-
heated environments and coupled with inadequate liquid in-
take, can impair body thermoregulatory mechanisms and lead
to life-threatening hyperthermia [20, 33, 34]. Body tempera-
tures up to 43.3 °C have been associated with such events as
the use of MDMA (“ecstasy”) [33].
In the present case, the thermogenic effects of α-PVP and
amphetamine, combined with sauna heat, likely caused a
marked elevation of the victim’s body temperature.
However, no PM diagnosis of hyperthermia was possible.
Establishing hyperthermia as the cause of death at autopsy is
indeed challenging, because changes are unspecific and occa-
sional (brain and lung edema; cutaneous, pleural, pericardial
petechiae), information on ambient temperature and on the
victims’ rectal temperature at the scene is hardly available,
and retrieval of victims in a sauna is often delayed.
Diagnosis of death due to hyperthermia thus remains mostly
one of exclusion, based on circumstantial and individual fac-
tors and the exclusion, at autopsy, of other causes of death
[35–38].
It is likely that the victim described here tookα-PVP before
his sauna shift, while planning to engage in paraphilic activi-
ties, possibly foreseeing the drugs effects on heightening his
sexual arousal. We are unaware whether this was the first time
the victim had consumed drugs and engaged in sexual activ-
ities while having a sauna. The sympathomimetic effects of α-
PVP and amphetamine, testified by the detection of myocar-
dial contraction band necrosis [39] and the additive effects of
α-PVP and amphetamine with sauna heat on the cardiovascu-
lar system and of dehydration, combined with an increasing
body core temperature seemingly contributed to the fatal out-
come. Moreover, respiratory depression caused by
buprenorphine and enhanced by benzodiazepines, as well as
the high levels of adrenaline associated with sexual activity,
evoked by the sexual props found at the scene, may well have
contributed to death. Buprenorphine, although found at a fair-
ly high level, was not considered crucial, since the low
buprenorphine to norbuprenorphine ratio did not suggest
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acute poisoning [40]. It can also be noted, as a matter of
general prevention, that timer-regulated locking of a sauna
door may delay first-aid intervention for solo sauna bathers
who experience any acute incapacitating medical condition,
although in our case this was not a relevant issue.
In conclusion, this case report highlights the risk of using
allegedly safe designer drugs, for instance α-PVP, in a sauna,
especially in association with other drugs and while engaging
in sexual activity.
Key points
1. Autoerotic accidental deaths (AAD) result from mechan-
ical asphyxia or can involve other types of sexual self-
stimulation.
2. We describe a unique case of AADs during a sauna asso-
ciated with use of α-PVP, amphetamine and other drugs.
3. The additive cardiovascular effects ofα-PVP and amphet-
amine, sauna heat and dehydration contributed to the fatal
outcome.
4. In saunas, using sympathomimetic and other drugs, espe-
cially while engaging in sexual activity can be life-
threatening.
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